These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24992089)

  • 1. Aripiprazole is effective for treatment of delayed sleep phase syndrome.
    Takaki M; Ujike H
    Clin Neuropharmacol; 2014; 37(4):123-4. PubMed ID: 24992089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low dose of aripiprazole advanced sleep rhythm and reduced nocturnal sleep time in the patients with delayed sleep phase syndrome: an open-labeled clinical observation.
    Omori Y; Kanbayashi T; Sagawa Y; Imanishi A; Tsutsui K; Takahashi Y; Takeshima M; Takaki M; Nishino S; Shimizu T
    Neuropsychiatr Dis Treat; 2018; 14():1281-1286. PubMed ID: 29849459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aripiprazole: pharmacodynamics of a dopamine partial agonist for the treatment of schizophrenia.
    Gründer G; Kungel M; Ebrecht M; Göröcs T; Modell S
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S21-5. PubMed ID: 16508892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aripiprazole as monotherapy at bedtime was effective for treatment of two cases of obsessive-compulsive disorder and insomnia.
    Takaki M
    J Neuropsychiatry Clin Neurosci; 2014; 26(3):E64. PubMed ID: 25093799
    [No Abstract]   [Full Text] [Related]  

  • 5. Improvement of a patient's circadian rhythm sleep disorders by aripiprazole was associated with stabilization of his bipolar illness.
    Tashiro T
    J Sleep Res; 2017 Apr; 26(2):247-250. PubMed ID: 28116759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity.
    Russo E; Citraro R; Davoli A; Gallelli L; Di Paola ED; De Sarro G
    Neuropharmacology; 2013 Jan; 64():371-9. PubMed ID: 22766393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Disappearance of paroxysmal perceptual alteration by switching to aripiprazole in a schizophrenic patient].
    Kondo M; Ikejiri Y; Hanatani T; Sumi N
    Seishin Shinkeigaku Zasshi; 2010; 112(1):23-30. PubMed ID: 20184237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
    Stip E; Tourjman V
    Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
    Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
    Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole, alcohol and substance abuse: a review.
    Brunetti M; Di Tizio L; Dezi S; Pozzi G; Grandinetti P; Martinotti G
    Eur Rev Med Pharmacol Sci; 2012 Oct; 16(10):1346-54. PubMed ID: 23104650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of aripiprazole for medication overuse headache: a case report.
    Yamada K; Makihara Y; Imamura Y
    Psychiatry Clin Neurosci; 2011 Apr; 65(3):296-8. PubMed ID: 21507137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole: a review of its pharmacology and clinical use.
    Taylor DM
    Int J Clin Pract; 2003; 57(1):49-54. PubMed ID: 12587943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective treatment of premenstrual violence in major depression: augmentation with aripiprazole.
    Yao YC; Chiang PH; Hsiao MC; Liu CY
    Chang Gung Med J; 2008; 31(4):402-6. PubMed ID: 18935799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aripiprazole: an overview of a novel antipsychotic.
    Uzun S; Kozumplik O; Mimica N; Folnegović-Smalc V
    Psychiatr Danub; 2005 Jun; 17(1-2):67-75. PubMed ID: 16395846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole: pharmacology, efficacy, safety and tolerability.
    Kinghorn WA; McEvoy JP
    Expert Rev Neurother; 2005 May; 5(3):297-307. PubMed ID: 15938662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
    Lu ML; Shen WW; Chen CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor compensatory function for sleep loss as a pathogenic factor in patients with delayed sleep phase syndrome.
    Uchiyama M; Okawa M; Shibui K; Liu X; Hayakawa T; Kamei Y; Takahashi K
    Sleep; 2000 Jun; 23(4):553-8. PubMed ID: 10875562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of dim light melatonin onset testing in diagnosing delayed sleep phase syndrome.
    Rahman SA; Kayumov L; Tchmoutina EA; Shapiro CM
    Sleep Med; 2009 May; 10(5):549-55. PubMed ID: 18725185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole for the treatment of Tourette syndrome: a case series of 100 patients.
    Wenzel C; Kleimann A; Bokemeyer S; Müller-Vahl KR
    J Clin Psychopharmacol; 2012 Aug; 32(4):548-50. PubMed ID: 22722499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aripiprazole use in children and adolescent psychiatric patients].
    Chevreuil C; Polard E; Lemonnier E; Guillemot P; Bentué-Ferrer D;
    Therapie; 2011; 66(2):123-30. PubMed ID: 21635859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.